BLTE vs JPM Stock Comparison

BLTE currently leads JPM in this stock comparison, with AIQ scores of 74 vs 65. The clearest difference is balanced, while JPM has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 9 points
BLTE
Healthcare
vs
JPM
Financial Services
BLTE
Belite Bio, Inc
Leads
Price
$164
Day move
-3.3%
AIQ Score
74/100
Best edge
Balanced
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between BLTE and JPM?

BLTE leads the current stock comparison as Belite Bio, Inc, with the clearest separation coming from balanced and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Belite Bio, Inc vs JPMorgan Chase & Co.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

BLTE leads

BLTE leads by 9 AIQ points.

Competitive: 3 of 5 evidence groups support BLTE, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Stable
BLTE

Belite Bio, Inc

Leads
AIQ Score
74/100
AIQ Edge Score
10/10
JPM

JPMorgan Chase & Co.

AIQ Score
65/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors BLTE over JPM, 74 versus 65 as of Nov 15, 2026. BLTE also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor BLTE today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. BLTE lead: Stable — the AIQ differential has held near 9 points over 30 sessions.

Compare Belite Bio, Inc and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BLTE
+1452.0%
JPM
+224.1%

Total return comparison

Growth of $10,000, distributions reinvested

BLTE $155,198 · JPM $32,409

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BLTE and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BLTE advantage
0
JPM advantage
  • Risk Resilience60 vs 87
    JPM +27
  • Quality85 vs 86
    Even
  • Momentum71 vs 70
    Even

3 of 5 evidence groups favor BLTE. Neither name separates cleanly on the covered dimensions.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BLTE+1 AIQ

Largest factor move: Momentum +4

New signals

  • RSI Bearish Divergence — bearish, momentum, medium horizon
JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

BLTE's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BLTE and JPM both carry a full feed there.

The central trade-off

BLTE (Belite Bio, Inc): the stronger current systematic profile.

JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BLTE

BLTE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

BLTE

BLTE on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

JPM

JPM on Risk Resilience, by 27 points.

Analyst upside

BLTE

BLTE on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBLTEJPMNote
Implied upside to target+58.6%+7.8%BLTE has more room
Target dispersion+26.5%+30.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering926Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor BLTE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBLTE74 vs 65
FundamentalsBLTEEPS growth -5.6% vs -27.6%
ValuationNot coveredNot covered
TechnicalsJPMPrice vs 50-day 2.2% vs 1.7%; vs 200-day 2.7% vs 6.6%
Risk ResilienceJPMRisk Resilience 60 vs 87
Analyst expectationsBLTETarget upside 58.6% vs 7.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BLTE and JPM and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 9 points.
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BLTE.

How the comparison changed

45 daily snapshots · Sep 14 – Nov 13

BLTE lead: Stable — the AIQ differential has held near 9 points over 30 sessions.

Sep 14BLTE leads above the line · JPM leads belowNov 13
Today
BLTE +9
74 vs 65
7 sessions ago
BLTE +8
72 vs 64
30 sessions ago
BLTE +9
72 vs 63
90 sessions ago
Not covered

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BLTEConflicted

5 bullish / 1 bearish / 1 neutral, conflicted

Only BLTE

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.07%)
  • Accumulation Pattern — bullish, volume, medium horizon (1.24x)
  • RSI Bearish Divergence — bearish, momentum, medium horizon
JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 4 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, MACD Histogram Expanding Bullish, Uptrend Structure Active.

BLTE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BLTEDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -3.3%, AIQ +1 points).

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
  2. 2BLTE's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
  3. 3A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

BLTE leads on balance
MetricBLTEJPM
Revenue growth (YoY)0%-7.6%
EPS growth (YoY)-5.6%-27.6%
Gross margin0%63.2%
Operating margin0%28.2%
Return on equity (TTM)0%4.1%
Debt to equity03.32

Performance

BLTE leads 4 of 6 windows
MetricBLTEJPM
1 week (5 sessions)6.6%3.5%
1 month (20 sessions)15.1%1.9%
3 months (63 sessions)0.7%-4.1%
6 months (126 sessions)14.9%16.2%
Year to date2.7%7.4%
1 year (252 sessions)48.3%8%

Technicals

JPM has the stronger structure
MetricBLTEJPM
RSI (14)57.356.1
ADX (14)19.318
Price vs 50-day2.2%1.7%
Price vs 200-day2.7%6.6%
Volatility (1M, annualized)59%27.4%

Risk

JPM is the more resilient
MetricBLTEJPM
Beta1.050.78
Sharpe ratio0.90.44
Sortino ratio1.460.61
Max drawdown-29.1%-15.5%
Current drawdown-15.1%-5.2%
Annualized volatility53.7%22.7%
Value at risk (95%)-4.7%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BLTE or JPM?

On the Algovestiq AIQ Score, BLTE is the stronger of the two as of Nov 15, 2026, scoring 74 against JPM's 65. The edge comes from its factor profile. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BLTE or JPM the better buy right now?

BLTE carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor BLTE over JPM?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 27 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BLTE or JPM?

Analyst price targets imply +58.6% upside for BLTE and +7.8% for JPM, so the Street currently favors BLTE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BLTE or JPM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BLTE or JPM?

BLTE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BLTE or JPM?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BLTE or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 27 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BLTE more profitable than JPM?

Margin data is not comparable for both names in the current snapshot.

Is BLTE's lead over JPM getting stronger or weaker?

BLTE lead: Stable — the AIQ differential has held near 9 points over 30 sessions. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has not changed hands in that window.

What would change the BLTE vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; BLTE's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BLTE and JPM?

BLTE: 5 bullish / 1 bearish / 1 neutral, conflicted. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BLTE is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare BLTE and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.